Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Stented Tissue Heart Valve Market Research Report 2026
Global Stented Tissue Heart Valve Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-01-08
Pages: 116 Pages
Report ld: 5586708
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Stented Tissue Heart Valve Market Size(US$)
CAGR 2026-2032
9.0%
Market Size,2032
USD 682
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 407 million
Market Forecast in 2032(Value)
US$ 682 million
CAGR
9.0%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Stented Tissue Heart Valve market was valued at US$ 376 million in 2025 and is anticipated to reach US$ 682 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Stented Tissue Heart Valve competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Stented Tissue Heart Valves are biologic valves that are made of animal tissue, usually porcine or bovine pericardium or valve tissue, and fixed to a metal or synthetic scaffold and are used to replace diseased heart valves in patients to improve hemodynamic function and reduce the risk of valve-related complications. This valve is designed to provide long-term, stable flow control during heart valve replacement surgery and to mimic the function of a native valve.
The North American market for Stented Tissue Heart Valve is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Stented Tissue Heart Valve is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Stented Tissue Heart Valve include Medtronic, Abbott, Edwards Lifesciences, LivaNova, Braile Biomedica, CryoLife, Inc, Meril Life Sciences Pvt. Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Stented Tissue Heart Valve market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stented Tissue Heart Valve. The Stented Tissue Heart Valve market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Stented Tissue Heart Valve market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Stented Tissue Heart Valve manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Medtronic
- Abbott
- Edwards Lifesciences
- LivaNova
- Braile Biomedica
- CryoLife, Inc
- Meril Life Sciences Pvt. Ltd
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Aortic-valve Replacement
- Mitral-valve Replacement
Segment by Application
- Hospital
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Stented Tissue Heart Valve manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Stented Tissue Heart Valve sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Stented Tissue Heart Valve Market Overview
1.1 Product Definition
1.2 Stented Tissue Heart Valve by Type
1.2.1 Global Stented Tissue Heart Valve Market Value by Type: 2025 vs 2032
1.2.2 Aortic-valve Replacement
1.2.3 Mitral-valve Replacement
1.3 Stented Tissue Heart Valve by Application
1.3.1 Global Stented Tissue Heart Valve Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Stented Tissue Heart Valve Market Size Estimates and Forecasts
1.4.1 Global Stented Tissue Heart Valve Revenue 2021–2032
1.4.2 Global Stented Tissue Heart Valve Sales 2021–2032
1.4.3 Global Stented Tissue Heart Valve Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Stented Tissue Heart Valve Market Competition by Manufacturers
2.1 Global Stented Tissue Heart Valve Sales Market Share by Manufacturers (2021–2026)
2.2 Global Stented Tissue Heart Valve Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Stented Tissue Heart Valve Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Stented Tissue Heart Valve, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Stented Tissue Heart Valve, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Stented Tissue Heart Valve, Product Types and Applications
2.7 Global Key Manufacturers of Stented Tissue Heart Valve, Date of Entry into the Industry
2.8 Global Stented Tissue Heart Valve Market Competitive Situation and Trends
2.8.1 Global Stented Tissue Heart Valve Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Stented Tissue Heart Valve Players Market Share by Revenue
2.8.3 Global Stented Tissue Heart Valve Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Stented Tissue Heart Valve Market Scenario by Region
3.1 Global Stented Tissue Heart Valve Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Stented Tissue Heart Valve Sales by Region: 2021–2032
3.2.1 Global Stented Tissue Heart Valve Sales by Region: 2021–2026
3.2.2 Global Stented Tissue Heart Valve Sales by Region: 2027–2032
3.3 Global Stented Tissue Heart Valve Revenue by Region: 2021–2032
3.3.1 Global Stented Tissue Heart Valve Revenue by Region: 2021–2026
3.3.2 Global Stented Tissue Heart Valve Revenue by Region: 2027–2032
3.4 North America Stented Tissue Heart Valve Market Facts & Figures by Country
3.4.1 North America Stented Tissue Heart Valve Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Stented Tissue Heart Valve Sales by Country (2021–2032)
3.4.3 North America Stented Tissue Heart Valve Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Stented Tissue Heart Valve Market Facts & Figures by Country
3.5.1 Europe Stented Tissue Heart Valve Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Stented Tissue Heart Valve Sales by Country (2021–2032)
3.5.3 Europe Stented Tissue Heart Valve Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Stented Tissue Heart Valve Market Facts & Figures by Region
3.6.1 Asia Pacific Stented Tissue Heart Valve Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Stented Tissue Heart Valve Sales by Region (2021–2032)
3.6.3 Asia Pacific Stented Tissue Heart Valve Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Stented Tissue Heart Valve Market Facts & Figures by Country
3.7.1 Latin America Stented Tissue Heart Valve Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Stented Tissue Heart Valve Sales by Country (2021–2032)
3.7.3 Latin America Stented Tissue Heart Valve Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Stented Tissue Heart Valve Market Facts & Figures by Country
3.8.1 Middle East and Africa Stented Tissue Heart Valve Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Stented Tissue Heart Valve Sales by Country (2021–2032)
3.8.3 Middle East and Africa Stented Tissue Heart Valve Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Stented Tissue Heart Valve Sales by Type (2021–2032)
4.1.1 Global Stented Tissue Heart Valve Sales by Type (2021–2026)
4.1.2 Global Stented Tissue Heart Valve Sales by Type (2027–2032)
4.1.3 Global Stented Tissue Heart Valve Sales Market Share by Type (2021–2032)
4.2 Global Stented Tissue Heart Valve Revenue by Type (2021–2032)
4.2.1 Global Stented Tissue Heart Valve Revenue by Type (2021–2026)
4.2.2 Global Stented Tissue Heart Valve Revenue by Type (2027–2032)
4.2.3 Global Stented Tissue Heart Valve Revenue Market Share by Type (2021–2032)
4.3 Global Stented Tissue Heart Valve Price by Type (2021–2032)
5 Segment by Application
5.1 Global Stented Tissue Heart Valve Sales by Application (2021–2032)
5.1.1 Global Stented Tissue Heart Valve Sales by Application (2021–2026)
5.1.2 Global Stented Tissue Heart Valve Sales by Application (2027–2032)
5.1.3 Global Stented Tissue Heart Valve Sales Market Share by Application (2021–2032)
5.2 Global Stented Tissue Heart Valve Revenue by Application (2021–2032)
5.2.1 Global Stented Tissue Heart Valve Revenue by Application (2021–2026)
5.2.2 Global Stented Tissue Heart Valve Revenue by Application (2027–2032)
5.2.3 Global Stented Tissue Heart Valve Revenue Market Share by Application (2021–2032)
5.3 Global Stented Tissue Heart Valve Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Stented Tissue Heart Valve Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Stented Tissue Heart Valve Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Stented Tissue Heart Valve Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott Stented Tissue Heart Valve Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Edwards Lifesciences
6.3.1 Edwards Lifesciences Company Information
6.3.2 Edwards Lifesciences Description and Business Overview
6.3.3 Edwards Lifesciences Stented Tissue Heart Valve Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Edwards Lifesciences Stented Tissue Heart Valve Product Portfolio
6.3.5 Edwards Lifesciences Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Company Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Stented Tissue Heart Valve Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 LivaNova Stented Tissue Heart Valve Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Braile Biomedica
6.5.1 Braile Biomedica Company Information
6.5.2 Braile Biomedica Description and Business Overview
6.5.3 Braile Biomedica Stented Tissue Heart Valve Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Braile Biomedica Stented Tissue Heart Valve Product Portfolio
6.5.5 Braile Biomedica Recent Developments/Updates
6.6 CryoLife, Inc
6.6.1 CryoLife, Inc Company Information
6.6.2 CryoLife, Inc Description and Business Overview
6.6.3 CryoLife, Inc Stented Tissue Heart Valve Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 CryoLife, Inc Stented Tissue Heart Valve Product Portfolio
6.6.5 CryoLife, Inc Recent Developments/Updates
6.7 Meril Life Sciences Pvt. Ltd
6.7.1 Meril Life Sciences Pvt. Ltd Company Information
6.7.2 Meril Life Sciences Pvt. Ltd Description and Business Overview
6.7.3 Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Product Portfolio
6.7.5 Meril Life Sciences Pvt. Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Stented Tissue Heart Valve Industry Chain Analysis
7.2 Stented Tissue Heart Valve Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Stented Tissue Heart Valve Production Mode & Process Analysis
7.4 Stented Tissue Heart Valve Sales and Marketing
7.4.1 Stented Tissue Heart Valve Sales Channels
7.4.2 Stented Tissue Heart Valve Distributors
7.5 Stented Tissue Heart Valve Customer Analysis
8 Stented Tissue Heart Valve Market Dynamics
8.1 Stented Tissue Heart Valve Industry Trends
8.2 Stented Tissue Heart Valve Market Drivers
8.3 Stented Tissue Heart Valve Market Challenges
8.4 Stented Tissue Heart Valve Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Stented Tissue Heart Valve Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Stented Tissue Heart Valve Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Stented Tissue Heart Valve Market Competitive Situation by Manufacturers in 2025
Table 4. Global Stented Tissue Heart Valve Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Stented Tissue Heart Valve Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Stented Tissue Heart Valve Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Stented Tissue Heart Valve Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Stented Tissue Heart Valve Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Stented Tissue Heart Valve, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Stented Tissue Heart Valve, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Stented Tissue Heart Valve, Product Types and Applications
Table 12. Global Key Manufacturers of Stented Tissue Heart Valve, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Stented Tissue Heart Valve Companies by Tier (Tier 1, Tier 2, Tier 3), based on Stented Tissue Heart Valve Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Stented Tissue Heart Valve Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Stented Tissue Heart Valve Sales by Region (Units), 2021–2026
Table 18. Global Stented Tissue Heart Valve Sales Market Share by Region (2021–2026)
Table 19. Global Stented Tissue Heart Valve Sales by Region (Units), 2027–2032
Table 20. Global Stented Tissue Heart Valve Sales Market Share by Region (2027–2032)
Table 21. Global Stented Tissue Heart Valve Revenue by Region (US$ Million), 2021–2026
Table 22. Global Stented Tissue Heart Valve Revenue Market Share by Region (2021–2026)
Table 23. Global Stented Tissue Heart Valve Revenue by Region (US$ Million), 2027–2032
Table 24. Global Stented Tissue Heart Valve Revenue Market Share by Region (2027–2032)
Table 25. North America Stented Tissue Heart Valve Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Stented Tissue Heart Valve Sales by Country (Units), 2021–2026
Table 27. North America Stented Tissue Heart Valve Sales by Country (Units), 2027–2032
Table 28. North America Stented Tissue Heart Valve Revenue by Country (US$ Million), 2021–2026
Table 29. North America Stented Tissue Heart Valve Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Stented Tissue Heart Valve Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Stented Tissue Heart Valve Sales by Country (Units), 2021–2026
Table 32. Europe Stented Tissue Heart Valve Sales by Country (Units), 2027–2032
Table 33. Europe Stented Tissue Heart Valve Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Stented Tissue Heart Valve Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Stented Tissue Heart Valve Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Stented Tissue Heart Valve Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Stented Tissue Heart Valve Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Stented Tissue Heart Valve Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Stented Tissue Heart Valve Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Stented Tissue Heart Valve Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Stented Tissue Heart Valve Sales by Country (Units), 2021–2026
Table 42. Latin America Stented Tissue Heart Valve Sales by Country (Units), 2027–2032
Table 43. Latin America Stented Tissue Heart Valve Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Stented Tissue Heart Valve Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Stented Tissue Heart Valve Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Stented Tissue Heart Valve Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Stented Tissue Heart Valve Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Stented Tissue Heart Valve Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Stented Tissue Heart Valve Revenue by Country (US$ Million), 2027–2032
Table 50. Global Stented Tissue Heart Valve Sales (Units) by Type (2021–2026)
Table 51. Global Stented Tissue Heart Valve Sales (Units) by Type (2027–2032)
Table 52. Global Stented Tissue Heart Valve Sales Market Share by Type (2021–2026)
Table 53. Global Stented Tissue Heart Valve Sales Market Share by Type (2027–2032)
Table 54. Global Stented Tissue Heart Valve Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Stented Tissue Heart Valve Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Stented Tissue Heart Valve Revenue Market Share by Type (2021–2026)
Table 57. Global Stented Tissue Heart Valve Revenue Market Share by Type (2027–2032)
Table 58. Global Stented Tissue Heart Valve Price (US$/Unit) by Type (2021–2026)
Table 59. Global Stented Tissue Heart Valve Price (US$/Unit) by Type (2027–2032)
Table 60. Global Stented Tissue Heart Valve Sales (Units) by Application (2021–2026)
Table 61. Global Stented Tissue Heart Valve Sales (Units) by Application (2027–2032)
Table 62. Global Stented Tissue Heart Valve Sales Market Share by Application (2021–2026)
Table 63. Global Stented Tissue Heart Valve Sales Market Share by Application (2027–2032)
Table 64. Global Stented Tissue Heart Valve Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Stented Tissue Heart Valve Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Stented Tissue Heart Valve Revenue Market Share by Application (2021–2026)
Table 67. Global Stented Tissue Heart Valve Revenue Market Share by Application (2027–2032)
Table 68. Global Stented Tissue Heart Valve Price (US$/Unit) by Application (2021–2026)
Table 69. Global Stented Tissue Heart Valve Price (US$/Unit) by Application (2027–2032)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Medtronic Stented Tissue Heart Valve Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Abbott Stented Tissue Heart Valve Product
Table 79. Abbott Recent Developments/Updates
Table 80. Edwards Lifesciences Company Information
Table 81. Edwards Lifesciences Description and Business Overview
Table 82. Edwards Lifesciences Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Edwards Lifesciences Stented Tissue Heart Valve Product
Table 84. Edwards Lifesciences Recent Developments/Updates
Table 85. LivaNova Company Information
Table 86. LivaNova Description and Business Overview
Table 87. LivaNova Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. LivaNova Stented Tissue Heart Valve Product
Table 89. LivaNova Recent Developments/Updates
Table 90. Braile Biomedica Company Information
Table 91. Braile Biomedica Description and Business Overview
Table 92. Braile Biomedica Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Braile Biomedica Stented Tissue Heart Valve Product
Table 94. Braile Biomedica Recent Developments/Updates
Table 95. CryoLife, Inc Company Information
Table 96. CryoLife, Inc Description and Business Overview
Table 97. CryoLife, Inc Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. CryoLife, Inc Stented Tissue Heart Valve Product
Table 99. CryoLife, Inc Recent Developments/Updates
Table 100. Meril Life Sciences Pvt. Ltd Company Information
Table 101. Meril Life Sciences Pvt. Ltd Description and Business Overview
Table 102. Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Meril Life Sciences Pvt. Ltd Stented Tissue Heart Valve Product
Table 104. Meril Life Sciences Pvt. Ltd Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Stented Tissue Heart Valve Distributors List
Table 108. Stented Tissue Heart Valve Customers List
Table 109. Stented Tissue Heart Valve Market Trends
Table 110. Stented Tissue Heart Valve Market Drivers
Table 111. Stented Tissue Heart Valve Market Challenges
Table 112. Stented Tissue Heart Valve Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Stented Tissue Heart Valve
Figure 2. Global Stented Tissue Heart Valve Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Stented Tissue Heart Valve Market Share by Type: 2025 & 2032
Figure 4. Aortic-valve Replacement Product Picture
Figure 5. Mitral-valve Replacement Product Picture
Figure 6. Global Stented Tissue Heart Valve Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Stented Tissue Heart Valve Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Stented Tissue Heart Valve Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Stented Tissue Heart Valve Market Size (US$ Million), 2021–2032
Figure 13. Global Stented Tissue Heart Valve Sales (Units), 2021–2032
Figure 14. Global Stented Tissue Heart Valve Average Price (US$/Unit), 2021–2032
Figure 15. Stented Tissue Heart Valve Report Years Considered
Figure 16. Stented Tissue Heart Valve Sales Share by Manufacturers in 2025
Figure 17. Global Stented Tissue Heart Valve Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Stented Tissue Heart Valve Players: Market Share by Revenue in Stented Tissue Heart Valve in 2025
Figure 19. Stented Tissue Heart Valve Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Stented Tissue Heart Valve Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Stented Tissue Heart Valve Sales Market Share by Country (2021–2032)
Figure 22. North America Stented Tissue Heart Valve Revenue Market Share by Country (2021–2032)
Figure 23. United States Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Stented Tissue Heart Valve Sales Market Share by Country (2021–2032)
Figure 26. Europe Stented Tissue Heart Valve Revenue Market Share by Country (2021–2032)
Figure 27. Germany Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Stented Tissue Heart Valve Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Stented Tissue Heart Valve Revenue Market Share by Region (2021–2032)
Figure 34. China Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Stented Tissue Heart Valve Sales Market Share by Country (2021–2032)
Figure 42. Latin America Stented Tissue Heart Valve Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Stented Tissue Heart Valve Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Stented Tissue Heart Valve Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Stented Tissue Heart Valve Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Stented Tissue Heart Valve by Type (2021–2032)
Figure 53. Global Revenue Market Share of Stented Tissue Heart Valve by Type (2021–2032)
Figure 54. Global Stented Tissue Heart Valve Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Stented Tissue Heart Valve by Application (2021–2032)
Figure 56. Global Revenue Market Share of Stented Tissue Heart Valve by Application (2021–2032)
Figure 57. Global Stented Tissue Heart Valve Price (US$/Unit) by Application (2021–2032)
Figure 58. Stented Tissue Heart Valve Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Stented Tissue Heart Valve in 2032?
The global market size of Stented Tissue Heart Valve in 2032 was 682 Million USD.
Which companies rank high in the global Stented Tissue Heart Valve market?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Stented Tissue Heart Valve market size from 2026 to 2032?
What was the global market size of Stented Tissue Heart Valve in 2026?
Related Reports
Global Stented Tissue Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Stented Tissue Heart Valve market is projected to grow from US$ 376 million in 2025 to US$ 682 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 136
USD 4900.00
(Single User License)
Global Stented Tissue Heart Valve Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stented Tissue Heart Valve market size was US$ 376 million in 2025 and is forecast to reach a readjusted size of US$ 682 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 76
USD 4250.00
(Single User License)
Stented Tissue Heart Valve- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 376 million in 2025 and is projected to reach US$ 682 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 93
USD 3950.00
(Single User License)
Global Stented Tissue Heart Valve Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Stented Tissue Heart Valve market size was US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
Global Stented Tissue Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stented Tissue Heart Valve market is projected to grow from US$ 348 million in 2024 to US$ 631 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 139
USD 4900.00
(Single User License)
Stented Tissue Heart Valve - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 96
USD 3950.00
(Single User License)
Global Stented Tissue Heart Valve Market Research Report 2025
The global market for Stented Tissue Heart Valve was valued at US$ 348 million in the year 2024 and is projected to reach a revised size of US$ 631 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
Global and United States Stented Tissue Heart Valve Market Report & Forecast 2024-2030
The global Stented Tissue Heart Valve revenue was US$ 320 million in 2023 and is forecast to a readjusted size of US$ 584 million by 2030 with a CAGR of 9.0% during the review period (2024-2030).
Published Date: 2024-12-26
Pages: 107
USD 4350.00
(Single User License)
Global Stented Tissue Heart Valve Market Insights, Forecast to 2030
Valued at US$ 348 million in 2024, the global Stented Tissue Heart Valve market is forecast to reach US$ 584 million by 2030, at a CAGR of 9.0% during the forecast period.
Published Date: 2024-12-26
Pages: 128
USD 4900.00
(Single User License)
Global Stented Tissue Heart Valve Market Research Report 2024
The global market for Stented Tissue Heart Valve was valued at US$ 320 million in the year 2023 and is projected to reach a revised size of US$ 584 million by 2030, growing at a CAGR of 9.0% during the forecast period.
Published Date: 2024-12-26
Pages: 78
USD 2900.00
(Single User License)
Global Stented Tissue Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Stented Tissue Heart Valve market is projected to grow from US$ 376 million in 2025 to US$ 682 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 136
USD 4900.00 (Single User License)Global Stented Tissue Heart Valve Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stented Tissue Heart Valve market size was US$ 376 million in 2025 and is forecast to reach a readjusted size of US$ 682 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 76
USD 4250.00 (Single User License)Stented Tissue Heart Valve- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 376 million in 2025 and is projected to reach US$ 682 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 93
USD 3950.00 (Single User License)Global Stented Tissue Heart Valve Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Stented Tissue Heart Valve market size was US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
USD 4250.00 (Single User License)Global Stented Tissue Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stented Tissue Heart Valve market is projected to grow from US$ 348 million in 2024 to US$ 631 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 139
USD 4900.00 (Single User License)Stented Tissue Heart Valve - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stented Tissue Heart Valve was estimated to be worth US$ 348 million in 2024 and is forecast to a readjusted size of US$ 631 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 96
USD 3950.00 (Single User License)Global Stented Tissue Heart Valve Market Research Report 2025
The global market for Stented Tissue Heart Valve was valued at US$ 348 million in the year 2024 and is projected to reach a revised size of US$ 631 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published: 2025-03-10
Pages: 87
USD 2900.00 (Single User License)Global and United States Stented Tissue Heart Valve Market Report & Forecast 2024-2030
The global Stented Tissue Heart Valve revenue was US$ 320 million in 2023 and is forecast to a readjusted size of US$ 584 million by 2030 with a CAGR of 9.0% during the review period (2024-2030).
Published: 2024-12-26
Pages: 107
USD 4350.00 (Single User License)Global Stented Tissue Heart Valve Market Insights, Forecast to 2030
Valued at US$ 348 million in 2024, the global Stented Tissue Heart Valve market is forecast to reach US$ 584 million by 2030, at a CAGR of 9.0% during the forecast period.
Published: 2024-12-26
Pages: 128
USD 4900.00 (Single User License)Global Stented Tissue Heart Valve Market Research Report 2024
The global market for Stented Tissue Heart Valve was valued at US$ 320 million in the year 2023 and is projected to reach a revised size of US$ 584 million by 2030, growing at a CAGR of 9.0% during the forecast period.
Published: 2024-12-26
Pages: 78
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now